| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1259.3 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1259.3/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1259.3 |
| Version | 20230206 |
| Status | active |
| Date | 2023-02-06T01:02:35-05:00 |
| Name | PrescribableBrandAndGenericInsulinsAndAnalogues |
| Title | Prescribable brand and generic insulins and analogues |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for both brand and generic prescribable insulins and insulin analogues used to manage hyperglycemia in Diabetes Mellitus),(Data Element Scope: Any medication data element which references prescribable, insulins and insulin analogues used to manage hyperglycemia in Diabetes Mellitus using SBD and SCD RxNorm TTYs),(Inclusion Criteria: Drugs containing an ingredient in the ATC1-4 class Insulins and Analogues, which are prescribable and have an RxNorm Term Type of Semantic Clinical Drug (SCD) or Semantic Branded Drug (SBD)),(Exclusion Criteria: Non-prescribable drugs or codes which are not of TTY SBD or SCD) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR